Our Services

As the official testing laboratory of the Emirati Genome Program and a key part of the M42 ecosystem, Biogenix applies population-scale omics to advance precision health, accelerate scientific discovery, and build life sciences economic value.

Biogenix delivers comprehensive, high-throughput NGS-based sequencing solutions across short-read and long-read technologies. Our workflow spans from sample collection to data interpretation, backed by sovereign data infrastructure, automated pipelines, and clinical-grade accuracy. Operating from the largest omics lab outside the USA, we support population genomics, translational research, and national health initiatives.

Biogenix offers NGS-based diagnostic programs and whole-genome sequencing with virtual panels designed for screening, early detection, and ongoing clinical care. As the official testing laboratory of the Emirati Genome Program, our diagnostic-grade solutions support national precision health strategies, health system programs, and pharmaceutical-funded testing initiatives, with clinical accuracy and population-scale efficiency

Biogenix's Population Omics Program applies genomics and an expanding omics data capability to uncover insights into health, disease, and population-specific traits. Built and proven through operating one of the world's most advanced national omics programs, this model enables health systems and governments worldwide to deliver precision health and build a thriving life sciences ecosystem.